PHAR, LLC presented research on schizophrenia management at the American Psychiatric Association’s 2010 Institute on Psychiatric Services. PHAR investigators conducted a retrospective cohort study of antipsychotic therapies, and findings from this study confirmed that adherence to antipsychotic treatment is an important determinant of health service use in general and hospitalization in particular. Outcomes may be improved in patients by choosing medications whose effect is less likely to be reduced by imperfect adherence-specifically those with longer half-lives.
Alvimopan Contributes to Lower Hospital Costs and Length of Stay After Bowel Resection
PHAR, LLC presented findings from an economic impact study on the use of alvimopan at the American College of Surgeons 96th Annual Clinical Congress. Results suggested that, along with other initiatives to improve quality and reduce costs of surgical care, alvimopan should be considered for use in the management of patients who undergo segmental bowel resection. PHAR investigators produced the study in collaboration with researchers at GlaxoSmithKline, UCLA Center for Surgical Outcomes and Quality, University of Colorado School of Pharmacy, EnPharma Consulting, and Adolor Corporation.